Thank you for visiting the BioBeOne website.
These days, even for large enterprises it takes longer than expected to develop and provide
innovative drugs and regenerative medical products for patients.
One way of overcoming this problem is through collaboration with suitable business partners.
Our mission is to help you find the best business partners in Japan and all over the world to ensure the steady progress of research and development through collaboration. We also aim to expedite the delivery of these products to patients who are desperately seeking treatment. To assist in these objectives we founded BioBeOne Inc.
Please join us and play a role in the global bridge to promote partnering and open innovation.
Founder, President and CEO
Basic membership registration is free. The following plans are available for BB1 System users:
Basic Plan : Free membership
Business Plan : Annual membership fee of 10,000 JPY (Approx. 100*US$)
Premium Plan : Annual membership fee of 30,000 JPY (Approx. 300*US$)
*: The amount in US dollars will vary depending on the exchange rate.
The BB1 System's automatic matching and notifications allow you to start a conversation with potential partners in an easy and efficient way. In other words, all you need do is register your project and allow our system to find and notify you of the matches. It ensures that your business development and licensing activities are carried out with efficiency.
The BB1 System is equipped with a high-quality proprietary messaging function enabling the disclosure of project information* and membership information. There is also a sub-membership function** that allows sub-members to share information with members in the same organization. This is very useful for project team members and leaders.
*: All members can view the project’s basic information.
**: Only available for Business and Premium membership plans.
This is an international partnering and open innovation service that automatically finds business partners in pharmaceuticals and regenerative medicine in Japan and all over the world. It provides the ability to enter into many possible collaborations in innovative pharmaceuticals and regenerative medicine worldwide.